HFA Premium Access

Safety, pharmacodynamic and pharmacokinetic characterisation of vericiguat: key results from six phase I studies in healthy subjects

Congress Presentation

About the speaker

Doctor Corina Becker

Bayer AG, Wuppertal (Germany)
0 follower

12 more presentations in this session

Optimal administration timing of thiazide diuretics for sequential nephron blockade in cardiovascular patients receiving loop diuretics

Speaker: Doctor J. Fallon (Cleveland, US)

Thumbnail

Super-response to sacubitril valsartan: prevalence and clinical profile

Speaker: Mr C. Moliner (Barcelona, ES)

Thumbnail

Who ARNI the best responders among patients with LVEF<35%?

Speaker: Doctor J. De Almeida (Coimbra, PT)

Thumbnail

Rationale, design and baseline characteristics of the Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE) randomized controlled trial

Speaker: Professor M. Ledwidge (Dublin, IE)

Thumbnail

Effect of empagliflozin on hydroelectrolytic balance in patients with heart failure with reduced ejection fraction

Speaker: Doctor S. Del Prado Diaz (Madrid, ES)

Thumbnail

Access the full session

Poster Session 2 - Pharmacology and Pharmacotherapy

Speakers: Doctor C. Becker, Doctor J. Fallon, Mr C. Moliner, Doctor J. De Almeida, Professor M. Ledwidge...
Thumbnail

About the event

Image

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk